September 15, 2026-September 16, 2026 Register Now: C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
August 27, 2026 From One to Millions: Julia Vitarello on a New Vision for Individualized Medicine "I'm very, very determined to play a role together with everyone at C-Path and others to try to make sure that the millions of kid
August 25, 2026 Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...
August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...
August 24, 2026 Successful Translational Prediction of Bedaquiline’s Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology Tuberculosis remains an urgent global health crisis that requires an accelerated development of novel regimens.
August 20, 2026 C-Path Achieves Internationally Recognized Certification for Information Security Management C-Path) today announced it has achieved certification to ISO/IEC 27001:2022, the internationally...
August 20, 2026 C-Path CEO Klaus Romero Talks One to Millions on The BioCentury Show Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies...
August 18, 2026 C-Path Receives FDA Qualification for Rheumatoid Arthritis Fatigue Measure TUCSON, Ariz., August 18, 2026 — Critical Path Institute’s® (C-Path) Patient-Centered Evidence Consortium today announced...
August 17, 2026 Amplifying the Voices Behind the Science: Celebrating National Nonprofit Day with Our Partners Every day, nonprofit organizations work on the most stubborn problems in global health.
August 6, 2026 C-Path’s Duchenne Consortium Awarded a $1.9 Million DoD Grant to Advance Understanding of Cardiomyopathy in Duchenne Muscular Dystrophy TUCSON, Ariz. August 6, 2026 — Critical Path Institute® (C-Path) today announced it has been awarded a grant in the amount...
